This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

VINCENT J. COLLINS, M.D.; EMERY A. ROVENSTINE, M.D.

AMA Arch Surg. 1962;84(6):680-685.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since 1885 every decade has had its popular local anesthetic agent. Witness the recent decades, when tetracaine hydrochloride (Pontocaine), lidocaine hydrochloride (Xylocaine) and hexylcaine hydrochloride (Cyclaine) rose successively to prominence and then receded into a niche of utility (Table 1). It is thus apparent that there remains an outstanding need in the practice of anesthesiology for the ideal agent. For the sake of completeness, the desirable characteristics of the ideal local anesthetic drug are listed (Table 2). Many drugs have been introduced to meet these specifications, but most fail in one respect or another. Many are being rapidly added to the list of potentially useful agents, and, indeed, it is difficult to evaluate them all thoroughly. However, as a result of the various screening studies and preliminary clinical testing we wish to recommend one drug, namely, mepivacaine hydrochloride (Carbocaine) with some confidence.

In the evaluation of this drug, 2 successive . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO; NEW YORK

Director, Department of Anesthesiology, Cook County Hospital, (Dr. Collins), and Professor of Anesthesiology, New York University-Bellevue Medical Center (Dr. Rovenstine).

Footnotes
Received for publication Aug. 21, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?